Mercaptor is pursuing non-dilutive funding for preclinical studies in models of stroke, TBI, Seizers, amyotrophic lateral sclerosis, and stroke. Proof-of-concept data will gate additional fundraising efforts. Our goal is to bring drug candidates to the clinical stage in both humans and companion animals.
